Product Information
LAMOTRIGINE ER 200 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.6085 per EA under NDC 55111072030. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111072030
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA202383FDA Approved
6/19/2013
TE Code
AB
On Market Since
6/20/2013
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE ER 200 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 93.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6085 per EA |
|---|---|
| All-time high | $10.9700 (Feb 12, 2014) |
| All-time low | $0.4877 (Nov 20, 2024) |
| 52-week high | $0.8174 |
| 52-week low | $0.6085 |
| Median price | $2.2980 |
| Average price | $3.5482 |
| Largest weekly change | -39.7% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 16 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 86% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE ER 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 200 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.6085 per EA (NDC 55111072030), effective Sep 30, 2026.
How has the price of LAMOTRIGINE ER 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE ER 200 MG TABLET has declined 93.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 200 MG TABLET?
Since Nov 28, 2013, the NADAC for LAMOTRIGINE ER 200 MG TABLET has ranged from a low of $0.4877 (Nov 20, 2024) to a high of $10.9700 (Feb 12, 2014), with a median of $2.2980 per EA.
Are there cheaper alternatives to LAMOTRIGINE ER 200 MG TABLET?
Yes. 16 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 200 MG TABLET, is $0.0825 per EA — about 86% below LAMOTRIGINE ER 200 MG TABLET.
Who manufactures LAMOTRIGINE ER 200 MG TABLET?
LAMOTRIGINE ER 200 MG TABLET (NDC 55111072030) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.